Millendo Therapeutics to Participate in September Investor Conferences
August 29 2019 - 08:30AM
Business Wire
Millendo Therapeutics, Inc. (Nasdaq: MLND), a clinical-stage
biopharmaceutical company developing novel treatments for orphan
endocrine diseases, today announced that senior management will
present company overviews and conduct one-on-one investor meetings
at the following healthcare investor conferences:
Citi’s 14th Annual Biotech Conference Date: Thursday,
September 5, 2019 (one-on-one meetings only) Location: Boston,
MA
Oppenheimer Fall Summit Focused on Specialty Pharma &
Rare Disease Companies Date: Monday, September 23, 2019
(one-on-one meetings only) Location: New York, NY
Ladenburg Thalmann 2019 Healthcare Conference Date/Time:
Tuesday, September 24, 2019 at 11:00 a.m. EDT Location: New York,
NY
A live webcast of the Ladenburg Thalmann presentation will be
available on the Investors & Media section of Millendo’s
website at http://investors.millendo.com. A replay of the webcast
will be archived on Millendo’s website for 30 days following the
presentation.
About Millendo Therapeutics, Inc. Millendo Therapeutics
is a late-stage biopharmaceutical company primarily focused on
developing novel treatments for orphan endocrine diseases where
current therapies do not exist or are insufficient. As a leading
orphan endocrine company, Millendo creates distinct and
transformative treatments where there is a significant unmet
medical need. The company is currently advancing livoletide for the
treatment of Prader-Willi syndrome, nevanimibe for the treatment of
classic congenital adrenal hyperplasia and MLE-301 for the
treatment of vasomotor symptoms associated with menopause. For more
information, please visit www.millendo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190829005139/en/
Millendo Investor Contact: Stephanie Ascher Stern
Investor Relations 212-362-1200 stephanie.ascher@sternir.com
Millendo Media Contact: Betsy Yates MacDougall 781-235-3094
byates@macbiocom.com
Millendo Therapeutics (NASDAQ:MLND)
Historical Stock Chart
From Feb 2024 to Mar 2024
Millendo Therapeutics (NASDAQ:MLND)
Historical Stock Chart
From Mar 2023 to Mar 2024